Zhejiang Yatai Pharmaceutical Co Ltd
002370
Company Profile
Business description
Zhejiang Yatai Pharmaceutical Co Ltd is a China-based company engaged in the research, production, and sales of pharmaceutical drugs. Its product portfolio includes tablets, hard capsules, transdermal patches, freeze-dried powder injections, powder injections, azithromycin, roxithromycin and other products. The company sells its products both in China and other international countries.
Contact
No. 1152, Yunji Road
Keqiao District, Zhejiang province
Shaoxing312030
CHNT: +86 57584815472
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
529
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,324.60 | 40.80 | 0.44% |
| CAC 40 | 8,206.07 | 17.48 | 0.21% |
| DAX 40 | 24,258.80 | 427.81 | 1.80% |
| Dow JONES (US) | 46,700.91 | 510.30 | 1.10% |
| FTSE 100 | 9,403.57 | 49.00 | 0.52% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 23,022.95 | 342.97 | 1.51% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
| S&P 500 | 6,740.88 | 76.87 | 1.15% |
| S&P/ASX 200 | 9,031.90 | 43.70 | 0.49% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |